These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Parallel decrease of glutamic acid decarboxylase and preproenkephalin mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and D2 agonist. Caboche J; Vernier P; Julien JF; Rogard M; Mallet J; Besson MJ J Neurochem; 1991 Feb; 56(2):428-35. PubMed ID: 1824860 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses. Winkler JD; Thermos K; Weiss B Psychopharmacology (Berl); 1987; 92(3):285-91. PubMed ID: 2957717 [TBL] [Abstract][Full Text] [Related]
7. Modulation of basal ganglia neurotransmission by the classical antipsychotic fluphenazine is due in part to the blockade of dopamine D1-receptors. Coirini H; Källström L; Wiesel FA; Johnson AE Brain Res Mol Brain Res; 1997 Oct; 49(1-2):197-210. PubMed ID: 9387879 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex. Damask SP; Bovenkerk KA; de la Pena G; Hoversten KM; Peters DB; Valentine AM; Meador-Woodruff JH Brain Res Mol Brain Res; 1996 Sep; 41(1-2):241-9. PubMed ID: 8883957 [TBL] [Abstract][Full Text] [Related]
9. Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons. Weiss-Wunder LT; Chesselet MF Neuroscience; 1992 Jul; 49(2):297-305. PubMed ID: 1359452 [TBL] [Abstract][Full Text] [Related]
10. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs. Cho S; Neff NH; Hadjiconstantinou M Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833 [TBL] [Abstract][Full Text] [Related]
11. Regional distribution and regulation of preprosomatostatin messenger RNA in the striatum, as revealed by in situ hybridization histochemistry. Weiss LT; Chesselet MF Brain Res Mol Brain Res; 1989 Mar; 5(2):121-30. PubMed ID: 2566104 [TBL] [Abstract][Full Text] [Related]
12. D2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors. Qin ZH; Zhou LW; Weiss B Neuroscience; 1994 May; 60(1):97-114. PubMed ID: 8052421 [TBL] [Abstract][Full Text] [Related]
13. Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivity. Schettini G; Ventra C; Florio T; Grimaldi M; Meucci O; Marino A J Neurochem; 1992 Nov; 59(5):1667-74. PubMed ID: 1402912 [TBL] [Abstract][Full Text] [Related]
14. D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors. Qin ZH; Zhou LW; Zhang SP; Wang Y; Weiss B Mol Pharmacol; 1995 Oct; 48(4):730-7. PubMed ID: 7476901 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic regulation of cholecystokinin mRNA content in rat striatum. Ding XZ; Mocchetti I Brain Res Mol Brain Res; 1992 Jan; 12(1-3):77-83. PubMed ID: 1312208 [TBL] [Abstract][Full Text] [Related]
16. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related]